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Abstract
Background: Basic science data suggest that acute kidney injury (AKI) induced by ischemia-reperfusion injury (IRI) is
an inflammatory process involving the adaptive immune response. Little is known about the T-cell contribution in
the very early phase, so we investigated if tubular cellular stress expressed by elevated cell cycle biomarkers is
associated with early changes in circulating T-cell subsets, applying a bedside-to-bench approach.
Methods: Our observational pilot study included 20 consecutive patients undergoing endovascular aortic repair for
aortic aneurysms affecting the renal arteries, thereby requiring brief kidney hypoperfusion and reperfusion. Clinical-grade
flow cytometry-based immune monitoring of peripheral immune cell populations was conducted perioperatively and
linked to tubular cell stress biomarkers ([TIMP-2]•[IGFBP7]) immediately after surgery. To confirm clinical results and
prove T-cell infiltration in the kidney, we simulated tubular cellular injury in an established mouse model of mild
renal IRI.
Results: A significant correlation between tubular cell injury and a peripheral decline of γδ T cells, but no other T-cell
subpopulation, was discovered within the first 24 hours (r = 0.53; p = 0.022). Turning to a mouse model of kidney warm
IRI, a similar decrease in circulating γδ T cells was found and concomitantly was associated with a 6.65-fold increase in
γδ T cells (p = 0.002) in the kidney tissue without alterations in other T-cell subsets, consistent with our human data. In
search of a mechanistic driver of IRI, we found that the damage-associated molecule high-mobility group box 1
protein HMGB1 was significantly elevated in the peripheral blood of clinical study subjects after tubular cell injury
(p = 0.019). Correspondingly, HMGB1 RNA content was significantly elevated in the murine kidney.
Conclusions: Our investigation supports a hypothesis that γδ T cells are important in the very early phase of human
AKI and should be considered when designing clinical trials aimed at preventing kidney damage.
Trial registration: ClinicalTrials.gov, NCT01915446. Registered on 5 Aug 2013.
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Background
Discovery of the cell cycle arrest biomarkers TIMP-2
and IGFBP7 (tissue inhibitor of metalloproteinase 2 and
insulin-like growth factor-binding protein 7, respect-
ively) enables the early detection of tubular cellular
stress [1]. When exposed to stress, epithelial tubular
cells may enter a short period of G1 cell-cycle arrest
until the danger has passed or the injury has been
repaired. The urinary biomarkers TIMP-2 and IGFBP7,
which are released in stressed cells as an “alarm signal”
for adjacent cells, have recently been established as early
predictors of imminent acute kidney injury (AKI) in gen-
eral and postoperative patients [2, 3]. The initiation of
early renal protection strategies in patients with elevated
stress markers TIMP-2 and IGFBP7 has recently reduced
the incidence and severity of postoperative AKI, thus
improving the short-term outcome in interventional ran-
domized trials [4, 5].
Stressed tubular cells may be sensed by the immune
system, similar to oncogenic stress in cancer cells. In
cancer, to prevent malignant cellular transformation,
stressed human cells are protected through cell-intrinsic
barriers, such as induction of cell-cycle arrest and apop-
tosis, and cell-extrinsic barriers, such as recognition by
the immune system and immune elimination [6]. In AKI
that has been recognized as a proinflammatory state,
equivalent scenarios may exist. Describing this early im-
mune response pathway could have an important impact
on future research, including the development of novel
therapeutic interventions. Current data suggest that T
cells play a key role in the initiation and propagation of
the immune reaction in experimental AKI [7, 8].
Therefore, we investigated in our pilot study if tubular
cellular stress expressed by elevated cell-cycle arrest bio-
markers is associated with early changes in circulating
T-cell subsets, using a bedside-to-bench approach. The
aim of the study was to obtain the first evidence that this
association exists. Renal ischemia-reperfusion injury
(IRI) is significantly associated with AKI and also occurs
during various surgical procedures in humans, including
the treatment of suprarenal aortic aneurysm. In the first
part of our study, we evaluated changes in circulating
T-cell subsets and their association with tubular cell
stress as measured by [TIMP-2]•[IGFPB7] in a clinical
setting. Subsequently, findings from the clinical setting
were further validated in murine kidneys within the first
24 hours after renal IRI in the experimental part of the
study. This bedside-to-bench approach was used to
prove the presence of immune cells in kidney tissue and
to confirm findings of the pilot clinical study.
Methods
The study was performed between November 2013 and
May 2017 at the University Hospital Regensburg.
Clinical study and patients
The clinical part of the study was performed first. In this
observational study, we included 20 consecutive patients
undergoing multibranched endovascular thoracoabdominal
aortic repair. Occlusion and intraluminal manipulation of
the renal artery during multibranched endovascular aortic
repair lead to a brief episode of kidney hypoperfusion and
reperfusion. Two patients were excluded: one because of
intraoperative interruption of aneurysm repair owing to
technical difficulties and one because of requirement of ur-
gent reoperation < 24 hours after surgery. Eligible patients
fulfilled the following four criteria: (1) adults (aged 18 years
or older), (2) elective repair of thoracoabdominal aortic
aneurysm, (3) presence of a central venous catheter for
repeated blood collection, and (4) provision of written
informed consent. Exclusion criteria were (1) preexisting
liver and kidney failure, defined as a spontaneous
international normalized ratio > 2 and encephalopathy, or
serum creatinine (SCr) > 2 mg/dl, or preoperative require-
ment of renal replacement therapy; and (2) anemia with
hemoglobin concentration of < 7 g/dl.
Ultrasound imaging was conducted at the bedside in a
standardized manner. A conventional ultrasound B-scan
was followed by color-coded Doppler sonography. Renal
perfusion was quantified by mean values of renal resist-
ive index measured in the renal artery and in the
interlobar arteries. All examinations were supervised and
analyzed at the bedside by a board-certified sonograph-
ist, according to German Society for Ultrasound in
Medicine guidelines. Postoperative AKI was defined ac-
cording to the 2012 Kidney Disease: Improving Global
Outcomes criteria [9].
The primary endpoint was change in circulating T-cell
subsets in subjects with tubular cellular stress. The key
secondary endpoints were incidence of AKI, changes in
circulating T cells and cellular infiltration of murine kid-
neys in histologically proven tubular injury, and values
of high-mobility group box 1 (HMGB1) in the clinical
and experimental studies.
Collection and analysis of blood and urine
Blood samples for measuring laboratory parameters such
as SCr, creatinine kinase, lactate, hemoglobin, interleukin
(IL)-6, C-reactive protein, and central venous oxygen
saturation were collected by central venous sampling
after the induction of anesthesia, before skin incision,
and at prespecified points after surgery (less than 4 hours
after the end of surgery and 24 hours after the start of
surgery). Urinary [TIMP-2]•[IGFBP7] was measured
simultaneously after surgery by means of the immuno-
assay method integrated in the Astute 140 Meter Kit
(Nephrocheck test; Astute Medical Inc., San Diego, CA,
USA). A cutoff value of [TIMP-2]•[IGFBP7] ≥ 0.3 was
used to identify tubular cellular stress and to predict
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AKI [10]. All values for [TIMP-2]•[IGFBP7] are reported
in units of (ng/ml)2/1000. Blood samples for immune
monitoring were collected directly into a Cyto-Chex®
BCT tube (Streck, Omaha, NE, USA) by central venous
sampling after the induction of anesthesia, before skin
incision, and 24 hours after the start of surgery. Immedi-
ately after collection, the contents of the Cyto-Chex®
tube were mixed by gentle inversion, and the tube was
immediately transported to the in-house immune moni-
toring laboratory. Samples were typically processed
within 30 minutes after blood collection; however, stand-
ard operating procedures allowed samples to be stored
at 4 °C for up to 4 hours before processing. To prepare
samples for analysis, 100 μl of whole blood was trans-
ferred from the Cyto-Chex® tube into a conical tube
(Sarstedt, Nürnbrecht, Germany). Unspecific binding
was blocked with 10 μl of human FcR blocking reagent
(Miltenyi Biotec, Bergisch Gladbach, Germany) in DPBS
without Ca2+ or Mg2+ (PAA Laboratories, Cölbe,
Germany) and incubated on ice for 30 minutes. Primary
conjugated antibodies were added in optimized amounts
to stain the cells at 4 °C for 1 hour. To remove erythro-
cytes, samples were incubated in 2 ml of 1 × BD lysing
solution (BD Biosciences, Heidelberg, Germany) at 4 °C
for 10 minutes before being washed twice with 2 ml of
DPBS. Samples were analyzed using a FACSCanto II cyt-
ometer (BD Biosciences) within 30 minutes of antibody
staining. As an internal stability control for cytometer
performance, a BD™ Cytometer Setup and Tracking
(CST) bead assay (BD Biosciences) was conducted before
each analysis. As many CD45+ events as possible were
recorded. Data were analyzed by a blinded operator
using FlowJo® software (FlowJo, Ashland, OR, USA).
Murine ischemia-reperfusion model
The experimental study was performed after analysis of
the clinical data. Six- to 8-week-old C57BL/6 mice
(Charles River Laboratories, Sulzfeld, Germany) under-
went kidney IRI as described elsewhere [11]. In brief, the
renal vessels were exposed bilaterally through a midline
incision and occluded with vascular clamps for 30 mi-
nutes. During the procedure, animals were kept at a con-
stant temperature (37 °C) and hydrated with warm saline.
After 24 hours, the mice were killed, and their organs
were harvested for further analysis. Sham-operated
animals (controls) were treated identically except for renal
artery occlusion. All animal experiments were conducted
upon approval by the Government of Upper Palatinate.
Flow cytometry
In mice, spleens and kidneys were harvested and proc-
essed to single-cell suspensions. Renal leukocytes were
isolated by mechanically disrupting renal tissue in 5 ml
of Paris buffer (20 mM Tris-HCl,125 mM NaCl, 10 mM
KCl, 10 mM glucose, pH 7.4). To remove debris,
samples were passed through a 100-μm cell strainer
(Falcon). The resulting cell suspension was centrifuged at
300 × g for 10 minutes to pellet the cells. The pellet was
then suspended in 36% Percoll (Amersham Pharmacia,
Stockholm, Sweden), gently overlaid onto 72% Percoll and
centrifuged at 1000 × g for 30 minutes at room
temperature. Cells were isolated from the Percoll interface
and washed twice in magnetic-activated cell sorting
(MACS) buffer at 300 × g at 4 °C for 10 minutes. Samples
were resuspended in 250 μl of MACS buffer. The number
of leukocytes was assessed using trypan blue exclusion on
a hemocytometer. Single-cell suspensions were then
stained with antibodies against CD3, CD4, CD8, and γδ
T-cell receptor (eBiosciences, Frankfurt, Germany), and
antigen expression was determined with a FACSCanto
flow cytometer (BD Biosciences). Data were analyzed with
FlowJo software.
Enzyme-linked immunosorbent assay
Human HMBG1 serum levels were analyzed with a
commercially available HMGB1 enzyme-linked immuno-
sorbent assay kit (IBL International, Hamburg, Germany)
according to the manufacturer’s instructions.
Real-time PCR
Murine kidney pieces were collected in RNAlater buffer
(Qiagen, Hilden, Germany) for further analysis. Com-
plementary DNA (cDNA) was isolated from murine
kidney samples using the μMACS ONEstep cDNA Kit
(Miltenyi Biotec). Relative gene expression changes
between GAPDH and HMGB1 were determined by
means of the comparative cycle threshold method.
The following QuantiTect Primer Sets (Qiagen) were
used: QT01658692 for GAPDH and QT02520210 for
HMGB1.
Statistical analysis
No formal sample size calculation was done for the pilot
study. A sample size of 20 was expected to yield
sufficient power to detect first effects and correlations.
Categorical data are presented as absolute numbers and
percentages. Continuous data are summarized as mean
(SD) or as median (IQR) and were compared using the
nonparametric Mann-Whitney U test, if not stated
otherwise. Pearson’s correlation coefficient was used to
assess correlations between continuous variables. The
level of significance was set to 5% without any adjust-
ments for multiple testing. Analyses were conducted
using Prism version 6 software (GraphPad Software, La
Jolla, CA, USA) and R version 3.2.1 (R Foundation for
Statistical Computing, Vienna, Austria).
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Results
In patients, tubular cellular stress/injury was associated
with loss of function
Baseline characteristics are shown in Table 1. A
schematic overview of our diagnostic trial is given in
Additional file 1: Figure S1a. Nine (50%) of 18 patients
undergoing endovascular aortic repair showed elevated
urinary cell stress biomarkers [TIMP-2]•[IGFBP-7]
within 4 hours after surgery. On the day after surgery,
patients with elevated biomarkers showed a 1.53-fold
(SD 0.33) mean increase in creatinine levels compared
with baseline values, whereas patients with physiological
biomarker levels only showed a 1.13-fold (SD 0.11) mean
elevation (Additional file 1: Figure S1b) (p = 0.021) and
thus had a significantly higher rate of AKI (OR, 12.25;
95% CI, 1.33–113.06; p = 0.027).
Postoperative renal perfusion was similar in both bio-
marker groups, as shown by mean arterial pressure over
the first 24 hours and standard Doppler sonography. Pa-
tients who developed early tubular cell stress required
longer duration of surgery and more blood transfusions
and had a more positive intraoperative fluid balance,
higher vasopressor dose, and higher SOFA score at admis-
sion than patients with urinary [TIMP-2][IGFBP-7] < 0.3
(Table 1, Additional file 1: Figure S1c).
γδ T cells were decreased in patient blood with elevated
biomarkers
All patients underwent clinical-grade standardized im-
mune monitoring (Fig. 1a). When comparing γδ T-cell
frequencies before and after surgery, we found that de-
clines in γδ T-cell frequencies were more pronounced in
the patient subset with elevated renal biomarkers (Fig. 1b).
Strikingly, the decrease in γδ T cells from the circulation
correlated with the value of urinary biomarkers (Fig. 1c)
(r = 0.53. p = 0.022). There was no correlation of postoper-
ative changes with other T-cell subsets in the first
24 hours. Similar results were found by evaluation of the
absolute cell count (Additional file 2: Figure S2) (r = 0.60,
p = 0.01).
Murine IRI leads to rapid γδ T-cell infiltration of the
kidneys
C57BL/6 mice showed a markedly increased level of
serum creatinine and urea within the first 24 hours after
standardized warm ischemia (Fig. 2a). In parallel, murine
kidneys showed histopathological features of early kid-
ney injury (Fig. 2b). Lymphocytes infiltrated the renal in-
terstitium, and infiltrates were analyzed by flow
cytometry. γδ T cells were increased 6.65-fold compared
with sham-operated controls (p = 0.002) in ischemic kid-
neys within the first 24 hours after injury, whereas levels
of other T-cell subsets tested were similar in both groups
(Fig. 2c). Similarly to the human setting, peripheral
(blood) murine γδ T cells were significantly reduced in IRI
mice as compared with controls (Fig. 3a left), showing that
γδ T cells home from blood to the kidneys after cellular
injury and induction of IRI.
HMGB1 correlates with murine IRI and human expression
of [TIMP-2]•[IGFBP7]
In search of a mechanistic driver of γδ T-cell homing, we
investigated the role of HMGB1. HMGB1 has recently
been described as a potent proinflammatory cytokine re-
leased from ischemia-reperfusion-injured cells. HMGB1
messenger RNA (mRNA) expression was significantly in-
creased in murine kidneys within the first 24 hours after
IRI (Fig. 3a, right). In humans, HMGB1 protein was sig-
nificantly elevated in biomarker-positive patients 1 day
after surgery compared with biomarker-negative patients
(median [IQR] 0.87 [0.68–1.82] versus 2.63 [1.59–12.20]
ng/ml, p = 0.019) (Fig. 3b).
Discussion
In the present study, we investigated the role of human
T cells in patients with renal tubular cellular stress and
found that the γδ T-cell subset is involved in the
first-line immune response in the very early phase of
AKI in both humans and mice. We were able to link the
decrease in circulating γδ T cells within first 24 hours to
elevated cellular stress biomarkers TIMP-2 and IGFBP7
measured 4 hours after surgery, suggesting that stressed/
injured tubular renal cells are recognized early by im-
mune stress surveillance. Accordingly, a drop of γδ T
cells in the blood of mice was associated with significant
cellular infiltration in the murine kidneys within the first
24 hours after cellular injury, suggesting that γδ T cells
traffic from the blood compartment to injured kidneys.
Finally, HMGB1 was elevated in mice and humans and
may serve as a link between local cellular injury and ag-
gravation of the systemic inflammatory response.
Injured epithelial cells are recognized by lymphoid
stress immunosurveillance [12, 13]. Interestingly, in
humans, γδ T cells as a minor fraction of T cells in per-
ipheral blood [14–16] are of increasing importance in
early first-line defense in various tissues, such as the
skin, brain, liver, and lungs [17–20]. The presence of
these cells in murine kidneys has been reported previ-
ously, but their role in human AKI is unclear [21].
In patients, perioperative decrease in circulating hu-
man γδ T-cell subpopulations within the first 24 hours
after surgery correlated with the values of cell injury bio-
markers in our study. No other T-cell subset showed this
early correlation. Because only biopsy specimens prove
the presence of γδ T cells in human kidneys during early
AKI, and because biopsies are not obtained in the care
of these patients, we simulated tubular cell injury in a
mouse model of mild renal IRI to prove γδ T-cell
Göcze et al. Critical Care  (2018) 22:168 Page 4 of 9
Table 1 Baseline perioperative characteristics and outcome parameters
Variables [TIMP-2•[IGFBP7] < 0.3
(n = 9)
[TIMP-2]•[IGFBP7] ≥ 0.3
(n = 9)
P value
Age, yr, median (IQR) 66.7 (58.3–71.6) 73.4 (69.9–73.9) 0.070
BMI, kg/m2, median (IQR) 28.4 (24.8–31.0) 28.1 (24.8–31.6) 1.00
Sex, female 2 3 0.624
Diabetes mellitus 1 2 0.527
Smoking 6 5 0.629
Coronary heart disease 4 5 0.637
Hypertension 8 8 1.000
SAPS II, median (IQR) 27 (20.5–40.0) 34 (27.0–53.5) 0.112
SOFA score at admission, median (IQR) 4.0 (1.0–8.0) 8.0 (5.0–9.5) 0.045
Ventilation days 0.0 (0.0–1.05) 0.75 (0.0–14.7) 0.219
Preoperative IL-6, mg/dl, median (IQR) 6.15 (5.22–20.95) 6.8 (5.55–13.10) 0.847
Preoperative hemoglobin, g/dl, median (IQR) 12.8 (11.15–14.25) 12.9 (11.05–13.75) 0.965
Preoperative lactate, mg/dl, median (IQR) 7.4 (6.00–8.50) 8.0 (7.00–8.60) 0.473
Preoperative ScvO2, %, median (IQR) 82.0 (77.00–86.65) 86.4 (84.35–87.85) 0.077
Intraoperative values, median (IQR)
Duration of surgery, min 281.0 (203.5–347.0) 422.0 (303.0–482.5) 0.031
Intravenous contrast agent, ml 240.0 (150.0–262.5) 250.0 (179.25–337.0) 0.469
Urine output, ml/h/kg 1.6 (1.50–2.80) 2.9 (1.70–4.75) 0.132
Fluid balance, ml 2420 (1850–3125) 3350 (2915–4474) 0.022
Blood transfusion, ml 0.00 (0.00–0.00) 600.0 (0.00–1500) 0.014
Noradrenalin, mg 0.85 (0.34–2.2) 4.6 (1.65–6.67) 0.012
MAP below 65 mmHg, % 0.00 (0.00–7.00) 0.00 (0.00–1.90) 0.599
Postoperative values, median (IQR), at admission ICU
Noradrenalin μg/kg/min 0.06 (0.0–0.15) 0.23 (0.07–0.30) 0.046
Creatinine, mg/dl 1.11 (0.95–1.39) 0.87 (0.71–1.09) 0.112
IL-6, mg/dl 66.0 (43.25–276.45) 406.9 (84.08–856.25) 0.102
Hemoglobin, g/dl 11.0 (9.3–13.35) 10.2 (9.80–12.35) 0.627
Lactate mg/dl 9.8 (6.10–13.95) 15.0 (9.5–18.60) 0.170
ScvO2, %, 76.2 (71.35–79.25) 78.4 (68.3–81.80) 0.427
Postoperative values, median (IQR), at 24 h
Mean arterial pressure 0–24 h after admission 76.1 (72.4–87.7) 75.7 (68.5–84.7) 0.310
Doppler RI both kidneys at 24 h 0.73 (0.67–0.76) 0.73 (0.72–0.80) 0.232
IL-6, mg/dl, at 24 h 167.8 (31.75–221.00) 185.1 (36.20–633.25) 0.354
Hemoglobin, g/dl, at 24 h 10.1 (8.35–12.5) 9.6 (8.4–11.05) 0.930
Lactate, mg/dl, at 24 h 11.4 (6.55–14.95) 14.0 (10.00–31.00) 0.122
ScvO2, %, at 24 h 68.9 (65.4–74.65) 76.2 (68.05–81.25) 0.200
Furosemide dose 0–24 h, mg 10.0 (0.0. 25.0) 30.0 (5.0–45.0) 0.133
Outcome parameters
AKI 2 7 0.02
AKI Stage 2 and 3 0 3 0.058
RRT 0 2 0.134
In-hospital mortality 0 2 0.134
Abbreviations: AKI Acute kidney injury, BMI Body mass index, CHD Coronary heart disease, CKD Chronic kidney disease, CK Creatinine kinase, CRP C-reactive
protein, Hb Hemoglobin, IL-6 Interleukin 6, MAP Mean arterial pressure, RRT Renal replacement therapy, SAPS Simplified Acute Physiology Score, SCr Serum
creatinine, ScvO2 Central venous oxygen saturation, TIMP-2 Tissue inhibitor of metalloproteinase, IGFBP7 Insulin-like factor-binding protein, RI Resistive index
Data are for patients with [TIMP-2]•[IGFBP7] low versus high
Note: Bold p values represent a statistically significant difference between the two groups
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infiltration in the kidney. Characterization of T-cells
subsets isolated from murine kidneys showed that γδ T
cells were significantly increased within the first 24 hours
after IRI, suggesting that these cells traffic to injured kid-
neys [22]. No early expansion of other tested detected T
cells was observed. Therefore, γδ T cells appear to act as
a mediator of early renal IRI, whereas other T-cell sub-
sets, such as CD4 and CD8 cells, are major likely effec-
tors of the immune response at a later stage [23]. This
finding may also suggest that the immune response is
triggered immediately after cellular stress/injury, hours
before the alteration of kidney function can be detected
with standard functional markers (such as serum cre-
atinine). Indeed, in a clinical scenario, these cells can be
activated upon aseptic tissue damage because they sense
danger signals such as phospholipids or markers of cell
injury [24]. A very recent analysis of 39 cancer types has
shown that intratumoral γδ T cells are the most signifi-
cant favorable prognostic immune population owing to
their response to stress signals expressed by tumor cells
[14]. γδ T-cell-based immunotherapy has been well
tolerated and efficient in clinical trials in patients with
advanced renal cell carcinoma [25], underscoring the po-
tential therapeutic use of this cell population for other
diseases as well.
Although our findings in both the mouse model and
the clinical setting showed that γδ T cells are involved in
the early immune response to kidney injury, it is not
clear how this response is triggered. HMGB1 protein
released from injured cells may either induce cell-cycle
arrest in epithelial cells [26] or modulate the immuno-
logical cascade through activating pattern recognition
Fig. 1 Correlation between human γδ T-cell subsets and biomarkers of kidney stress. a Gating strategy used for flow cytometric analysis.
Following exclusion of doublets, CD45+ cells were analyzed and further specified according to size/granularity. γδ T cells were defined as
CD3+Vδ2+ cells. b Perioperative changes in human peripheral γδ T-cell frequencies were analyzed and stratified by biomarker results. In patients
with elevated biomarkers, greater changes could be observed. c Perioperative changes (postsurgery versus presurgery) of T-cell subsets in human
peripheral blood, including γδ T cells, were correlated with the biomarker level ([TIMP-2]•[IGFBP7]). Here, only changes in the γδ T-cell subpopulation
significantly correlated with biomarker testing (p = 0.022), whereas no significant correlation could be observed in the (global) CD3 population or
CD4/CD8 T-cell subsets
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Fig. 2 Murine ischemia-reperfusion model. a Thirty minutes of warm ischemia induced a highly significant increase in creatinine (left) and urea
(right) after 24 hours. b Accordingly, histology (H&E staining) showed acute tubular injury with immune cell infiltration. Original magnification
200 ×. c Characterization of T-cell subsets isolated from murine kidneys (n = 6 per group) showed that γδ T cells, in contrast to other T-cell
subpopulations, were significantly increased after ischemia-reperfusion injury. Data are shown as mean values with SEM. The Mann-Whitney U test
was used to determine statistical significance. n.s. Not significant. **p < 0.01; ****p < 0.0001
Fig. 3 HMGB1 as a potential driver of γδ T-cell response. a In the murine ischemia-reperfusion injury (IRI) model, the pattern of peripheral γδ T-cell
changes was similar to that in the human samples (see Fig. 1c). Here, peripheral γδ T-cell frequency was significantly reduced after IRI (left, p = 0.036).
Interestingly, HMGB1 gene expression was significantly increased in murine kidneys (right, p < 0.0001). b In study participants, the HMGB1 protein was
increased in the peripheral blood on day 1 after surgery. Strikingly, biomarker-positive study subjects had significantly higher HMGB1 levels on day 1
than biomarker-negative patients (p= 0.019). All data are shown as means with SEM and were evaluated for significance using the Mann-Whitney U test
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receptors in immune cells [22]. Therefore, HMBG1 may
serve as a link between cell damage and activation of the
systemic inflammatory response [27, 28]. Indeed,
HMGB1 mRNA expression was significantly increased
in murine kidneys within 24 hours after IRI in our study.
Analogously, surgical patients showed a marked HMGB1
increase in [TIMP-2]•[IGFBP7] biomarker-positive pa-
tients after 1 day. Although our findings may support
the hypothesis that HMGB1 is released from injured epi-
thelial tubular cells, we have not yet examined whether
HMGB1 is the driver of γδ T-cell expansion. However,
HMGB1 has already been shown to be critical in indu-
cing IL-17-producing γδ T cells via Toll-like receptor 4
(TLR4) activation on macrophages and blockade of
HMGB1 suppressed IL-17+ γδ T-cell response [20, 29].
Furthermore, damage-associated molecular patterns re-
leased after tissue/cellular injury are capable of activating
dermal and splenic γδ T cells, leading to increased TLR
expression and cytokine, chemokine, and growth factor
release [30, 31]. Our data contribute to the published
role of HMGB1 in amplifying inflammation [32–34].
Our study has some limitations. As mentioned above,
the ultimate proof of γδ T-cell infiltration in human kid-
neys early after AKI may be provided only by timed kid-
ney biopsies that were not available because of the
design of our observational trial. Furthermore, although
the nine patients in each study group showed unambigu-
ous results, the sample size was small. We also point out
that the mouse IRI model and the corresponding
homogeneous cohort of patients undergoing endovascu-
lar aortic surgery may not be generalizable to all patients
with AKI.
Conclusions
Our bedside-to-bench approach is the first demonstra-
tion that γδ T cells are involved in the early immune re-
sponse after renal cell injury brought on by IRI in both
mice and humans. These cells traffic to the kidney, and
their decrease in blood correlates with a greater level of
tubular cell injury evidenced by TIMP2 and IGFBP7.
HMGB1 is released from injured renal cells and may fur-
ther amplify the immune reaction. These findings
support the hypothesis that the immune response is ini-
tiated immediately after cellular stress/injury before AKI
becomes evident, and the future immunological inter-
ventions may rather be triggered by early cellular injury
markers than by standard markers of kidney function.
The results of our study may pave the way for future in-
vestigation of γδ T cells in biomarker-positive patients in
larger cohorts of patients. Because human AKI is
difficult to prevent in the clinical setting, γδ T cells
may represent an early marker of systemic immune
activation in early AKI and a possible target for
future early interventions.
Additional files
Additional file 1: Figure S1. a Schematic overview of the study.
b Creatinine change over time, stratified according to the risk score.
Patients with elevated biomarkers showed a marked creatinine increase
on day 1 compared with their baseline values. Data are mean with SEM.
p = 0.021, Mann-Whitney U test. Biomarker-negative patients had no
relevant creatinine alteration. c Relevant baseline parameters of study
patients, stratified by risk score immediately after surgery. Data are given
as median with IQR. n.s. Not significant. *p < 0.05. (JPG 120 kb)
Additional file 2: Figure S2. Perioperative changes (postsurgery versus
presurgery) of T-cell subsets in human peripheral blood, including γδ T
cells, were correlated with biomarker levels ([TIMP-2]•[IGFBP7]). In contrast
to Fig. 1c, data are shown as absolute cell numbers. Again, no significant
associations were observed between cell number differences and
biomarker levels for CD3, CD4, or CD8 T-cell subsets. In the γδ T-cell
compartment, however, the extent of cell number differences was
significantly correlated with biomarker values (p = 0.01). (JPG 90 kb)
Availability of data and materials
The datasets used and/or analyzed during the current study are available
from the corresponding author on reasonable request.
Authors’ contributions
IG, EKG, PK, HJS, EE, and PRe were responsible for the study design and for
administering the protocol. KE, IG, PRe, KP, and FZ collected and analyzed
the clinical data. EE and PRe performed the experiments and analyzed the
experimental data. PRi and JAH performed the immunological analysis. IG, BMG,
EKG, HJS, TB, JAK, EE, and PRe wrote and reviewed the manuscript for important
intellectual content. All authors read and approved the final manuscript.
Ethics approval and consent to participate
The study protocol was approved by the local institutional review board
(University of Regensburg Ethics Committee, no. 13-101-0027). Written
consent was obtained from all patients prior to study entry. The study is
registered with ClinicalTrials.gov (NCT01915446).
Consent for publication
Not applicable.
Competing interests
JAK has received grant support and consulting fees from Astute Medical
unrelated to the current study. IG have received lecture fees from Astute
Medical unrelated to the current study. PR was supported by a research
grant from the German Interdisciplinary Association of Intensive Care and
Emergency Medicine. All of the other authors declare that they have no
competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Department of Surgery, Surgical Intensive Care and Experimental Surgery,
University Medical Center Regensburg, Regensburg, Germany. 2Department
of Anesthesia, University Medical Center Regensburg, Regensburg, Germany.
3Center for Clinical Studies, University Medical Center Regensburg,
Regensburg, Germany. 4Department of Vascular and Endovascular Surgery,
University Medical Center Regensburg, Regensburg, Germany. 5Center for
Critical Care Nephrology, Department of Critical Care Medicine, University of
Pittsburgh, Pittsburgh, PA 15621, USA.
Received: 13 April 2018 Accepted: 12 June 2018
References
1. Kashani K, Al-Khafaji A, Ardiles T, Artigas A, Bagshaw SM, Bell M, Bihorac A,
Birkhahn R, Cely CM, Chawla LS, et al. Discovery and validation of cell cycle
arrest biomarkers in human acute kidney injury. Crit Care. 2013;17(1):R25.
Göcze et al. Critical Care  (2018) 22:168 Page 8 of 9
2. Bihorac A, Chawla LS, Shaw AD, Al-Khafaji A, Davison DL, Demuth GE,
Fitzgerald R, Gong MN, Graham DD, Gunnerson K, et al. Validation of
cell-cycle arrest biomarkers for acute kidney injury using clinical
adjudication. Am J Respir Crit Care Med. 2014;189(8):932–9.
3. Gocze I, Renner P, Graf BM, Schlitt HJ, Bein T, Pfister K. Simplified
approach for the assessment of kidney perfusion and acute kidney
injury at the bedside using contrast-enhanced ultrasound. Intensive
Care Med. 2015;41(2):362–3.
4. Meersch M, Schmidt C, Hoffmeier A, Van Aken H, Wempe C, Gerss J,
Zarbock A. Prevention of cardiac surgery-associated AKI by
implementing the KDIGO guidelines in high risk patients identified by
biomarkers: the PrevAKI randomized controlled trial. Intensive Care Med.
2017;43(11):1551–61.
5. Göcze I, Jauch D, Götz M, Kennedy P, Jung B, Zeman F, Gnewuch C,
Graf BM, Gnann W, Banas B, et al. Biomarker-guided intervention to prevent
acute kidney injury after major surgery: the prospective randomized BigpAK
study. Ann Surg. 2018;267(6):1013–20.
6. Raulet DH, Guerra N. Oncogenic stress sensed by the immune system: role
of natural killer cell receptors. Nat Rev Immunol. 2009;9(8):568–80.
7. Andres-Hernando A, Okamura K, Bhargava R, Kiekhaefer CM, Soranno D,
Kirkbride-Romeo LA, Gil HW, Altmann C, Faubel S. Circulating IL-6
upregulates IL-10 production in splenic CD4+ T cells and limits acute kidney
injury-induced lung inflammation. Kidney Int. 2017;91(5):1057–69.
8. Weller S, Varrier M, Ostermann M. Lymphocyte function in human acute
kidney injury. Nephron. 2017;137(4):287–93.
9. Kellum JA, Lameire N, KDIGO AKI Guideline Work Group. Diagnosis,
evaluation, and management of acute kidney injury: a KDIGO summary
(Part 1). Crit Care. 2013;17(1):204.
10. Hoste EA, McCullough PA, Kashani K, Chawla LS, Joannidis M, Shaw AD,
Feldkamp T, Uettwiller-Geiger DL, McCarthy P, Shi J, et al. Derivation and
validation of cutoffs for clinical use of cell cycle arrest biomarkers. Nephrol
Dial Transplant. 2014;29(11):2054–61.
11. Linkermann A, Brasen JH, Himmerkus N, Liu S, Huber TB, Kunzendorf U,
Krautwald S. Rip1 (receptor-interacting protein kinase 1) mediates
necroptosis and contributes to renal ischemia/reperfusion injury. Kidney Int.
2012;81(8):751–61.
12. Chien YH, Meyer C, Bonneville M. γδ T cells: first line of defense and
beyond. Annu Rev Immunol. 2014;32:121–55.
13. Hayday AC. γδ T cells and the lymphoid stress-surveillance response.
Immunity. 2009;31(2):184–96.
14. Gentles AJ, Newman AM, Liu CL, Bratman SV, Feng W, Kim D, Nair VS, Xu Y,
Khuong A, Hoang CD, et al. The prognostic landscape of genes and
infiltrating immune cells across human cancers. Nat Med. 2015;21(8):938–45.
15. Shichita T, Sugiyama Y, Ooboshi H, Sugimori H, Nakagawa R, Takada I, Iwaki T,
Okada Y, Iida M, Cua DJ, et al. Pivotal role of cerebral interleukin-17-producing
γδT cells in the delayed phase of ischemic brain injury. Nat Med.
2009;15(8):946–50.
16. Vantourout P, Hayday A. Six-of-the-best: unique contributions of
gammadelta T cells to immunology. Nat Rev Immunol. 2013;13(2):88–100.
17. Eggenhofer E, Rovira J, Sabet-Baktach M, Groell A, Scherer MN, Dahlke MH,
Farkas SA, Loss M, Koehl GE, Lang SA, et al. Unconventional RORγt+ T cells
drive hepatic ischemia reperfusion injury. J Immunol. 2013;191(1):480–7.
18. Gelderblom M, Arunachalam P, Magnus T. γδ T cells as early sensors of
tissue damage and mediators of secondary neurodegeneration. Front Cell
Neurosci. 2014;8:368.
19. Rani M, Zhang Q, Oppeltz RF, Schwacha MG. Gamma delta T cells regulate
inflammatory cell infiltration of the lung after trauma-hemorrhage. Shock.
2015;43(6):589–97.
20. Wang X, Sun R, Wei H, Tian Z. High-mobility group box 1 (HMGB1)-Toll-like
receptor (TLR)4-interleukin (IL)-23-IL-17A axis in drug-induced damage-
associated lethal hepatitis: interaction of γδ T cells with macrophages.
Hepatology. 2013;57(1):373–84.
21. Savransky V, Molls RR, Burne-Taney M, Chien CC, Racusen L, Rabb H. Role of
the T-cell receptor in kidney ischemia-reperfusion injury. Kidney Int.
2006;69(2):233–8.
22. Mulay SR, Linkermann A, Anders HJ. Necroinflammation in kidney disease.
J Am Soc Nephrol. 2016;27(1):27–39.
23. Kinsey GR, Okusa MD. Role of leukocytes in the pathogenesis of acute
kidney injury. Crit Care. 2012;16(2):214.
24. Marlin R, Pappalardo A, Kaminski H, Willcox CR, Pitard V, Netzer S, Khairallah C,
Lomenech AM, Harly C, Bonneville M, et al. Sensing of cell stress by human γδ
TCR-dependent recognition of annexin A2. Proc Natl Acad Sci U S A. 2017;
114(12):3163–8.
25. Zou C, Zhao P, Xiao Z, Han X, Fu F, Fu L. γδ T cells in cancer
immunotherapy. Oncotarget. 2017;8(5):8900–9.
26. Zarbock A, Schmidt C, Van Aken H, Wempe C, Martens S, Zahn PK, Wolf B,
Goebel U, Schwer CI, Rosenberger P, et al. Effect of remote ischemic
preconditioning on kidney injury among high-risk patients undergoing
cardiac surgery: a randomized clinical trial. JAMA. 2015;313(21):2133–41.
27. Chen CB, Liu LS, Zhou J, Wang XP, Han M, Jiao XY, He XS, Yuan XP.
Up-regulation of HMGB1 exacerbates renal ischemia-reperfusion injury by
stimulating inflammatory and immune responses through the TLR4
signaling pathway in mice. Cell Physiol Biochem. 2017;41(6):2447–60.
28. Rabb H, Griffin MD, McKay DB, Swaminathan S, Pickkers P, Rosner MH,
Kellum JA, Ronco C, Acute Dialysis Quality Initiative Consensus XIII Work
Group. Inflammation in AKI: current understanding, key questions, and
knowledge gaps. J Am Soc Nephrol. 2016;27(2):371–9.
29. Xia Q, Duan L, Shi L, Zheng F, Gong F, Fang M. High-mobility group box 1
accelerates early acute allograft rejection via enhancing IL-17+ γδ T-cell
response. Transpl Int. 2014;27(4):399–407.
30. Schwacha MG, Rani M, Nicholson SE, Lewis AM, Holloway TL, Sordo S, Cap AP.
Dermal γδ T-cells can be activated by mitochondrial damage-associated
molecular patterns. PLoS One. 2016;11(7):e0158993.
31. Schwacha MG, Rani M, Zhang Q, Nunez-Cantu O, Cap AP. Mitochondrial
damage-associated molecular patterns activate γδ T-cells. Innate Immun.
2014;20(3):261–8.
32. Goligorsky MS. TLR4 and HMGB1: partners in crime? Kidney Int.
2011;80(5):450–2.
33. Shirali AC, Goldstein DR. Tracking the toll of kidney disease. J Am Soc
Nephrol. 2008;19(8):1444–50.
34. Tang D, Kang R, Zeh HJ 3rd, Lotze MT. High-mobility group box 1, oxidative
stress, and disease. Antioxid Redox Signal. 2011;14(7):1315–35.
Göcze et al. Critical Care  (2018) 22:168 Page 9 of 9
